Current and Future Perspectives of Stem Cell Therapy in Dermatology

키워드

참고문헌 (173)

1. Lanza RP, "Essentials of stem cell biology", pp.23~93 (2014), Academic Press
2. Verfaillie CM, "Stem cells : hype and reality", Hematology Am Soc Hematol Educ Program, pp.369~391 (2002)
3. Thomson JA, "Embryonic stem cell lines derived from human blastocysts", Science, 282, pp.1145~1147 (1998)
4. Williams JM, "Cell therapy", pp.3~14 (2008), McGraw Hill-Interamerican
5. Blanpain C, "Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche", Cell, 118, pp.635~648 (2004)
6. Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells", Science, 284, pp.143~147 (1999)
7. Takahashi K, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors", Cell, 126, pp.663~676 (2006)
8. Okita K, "Generation of germlinecompetent induced pluripotent stem cells", Nature, 448, pp.313~317 (2007)
9. Yu J, "Induced pluripotent stem cell lines derived from human somatic cells", Science, 318, pp.1917~1920 (2007)
10. Takahashi K, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors", Cell, 131, pp.861~872 (2007)
11. Stadtfeld M, "Induced pluripotent stem cells generated without viral integration", Science, 322, pp.945~949 (2008)
12. Yu J, "Human induced pluripotent stem cells free of vector and transgene sequences", Science, 324, pp.797~801 (2009)
13. Zhou H, "Generation of induced pluripotent stem cells using recombinant proteins", Cell Stem Cell, 4, pp.381~384 (2009)
14. Warren L, "Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA", Cell Stem Cell, 7, pp.618~630 (2010)
15. Shi Y, "Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds", Cell Stem Cell, 3, pp.568~574 (2008)
16. Kumar D, "Transposon-based reprogramming to induced pluripotency", Histol Histopathol, 30, pp.1397~1409 (2015)
17. Bilousova G, "Induced pluripotent stem cells in dermatology: potentials, advances, and limitations", Cold Spring Harb Perspect Med, 4, pp.a015164~ (2014)
18. Beaver CM, "Clonogenicity: holoclones and meroclones contain stem cells", PLoS One, 9, pp.e89834~ (2014)
19. Gola M, "Melanocyte stem cells: biology and current aspects", Med Sci Monit, 18, pp.RA155~RA159 (2012)
20. Nemeth K, "Bone marrow stromal cells as immunomodulators. A primer for dermatologists", J Dermatol Sci, 77, pp.11~20 (2015)
21. Tanabe S, "Signaling involved in stem cell reprogramming and differentiation", World J Stem Cells, 7, pp.992~998 (2015)
22. Van Camp JK, "Wnt signaling and the control of human stem cell fate", Stem Cell Rev, 10, pp.207~229 (2014)
23. Ring A, "Wnt", catenin signaling in adult stem cell physiology and disease, 2014, pp.10, 512~525
24. Blanpain C, "Epidermal stem cells of the skin", Annu Rev Cell Dev Biol, 22, pp.339~373 (2006)
25. Barrandon Y, "Three clonal types of keratinocyte with different capacities for multiplication", Proc Natl Acad Sci U S A, 84, pp.2302~2306 (1987)
26. Claudinot S, "Long-term renewal of hair follicles from clonogenic multipotent stem cells", Proc Natl Acad Sci U S A, 102, pp.14677~14682 (2005)
27. Blanpain C, "Epidermal homeostasis: a balancing act of stem cells in the skin", Nat Rev Mol Cell Biol, 10, pp.207~217 (2009)
28. Senoo M, "Epidermal stem cells in homeostasis and wound repair of the skin", Adv Wound Care (New Rochelle), 2, pp.273~282 (2013)
29. Rompolas P, "Spatiotemporal coordination of stem cell commitment during epidermal homeostasis", Science, 352, pp.1471~1474 (2016)
30. Hsu YC, "Emerging interactions between skin stem cells and their niches", Nat Med, 20, pp.847~856 (2014)
31. Ovadia J, "Stem cell niche structure as an inherent cause of undulating epithelial morphologies", Biophys J, 104, pp.237~246 (2013)
32. Choi HR, "Niche interactions in epidermal stem cells", World J Stem Cells, 7, pp.495~501 (2015)
33. Kaur P, "Adhesive properties of human basal epidermal cells: an analysis of keratinocyte stem cells, transit amplifying cells, and postmitotic differentiating cells", J Invest Dermatol, 114, pp.413~420 (2000)
34. Kretzschmar K, "Markers of epidermal stem cell subpopulations in adult mammalian skin", Cold Spring Harb Perspect Med, 4, pp.a013631~ (2014)
35. Pellegrini G, "p63 identifies keratinocyte stem cells", Proc Natl Acad Sci U S A, 98, pp.3156~3161 (2001)
36. Cotsarelis G, "Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis", Cell, 61, pp.1329~1337 (1990)
37. Ito M, "Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis", Nat Med, 11, pp.1351~1354 (2005)
38. Clewes O, "Human epidermal neural crest stem cells (hEPI-NCSC)--characterization and directed differentiation into osteocytes and melanocytes", Stem Cell Rev, 7, pp.799~814 (2011)
39. Ghazizadeh S, "Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin", EMBO J, 20, pp.1215~1222 (2001)
40. Lang D, "Melanocytes, melanocyte stem cells, and melanoma stem cells", Clin Dermatol, 31, pp.166~178 (2013)
41. Fernandes KJ, "A dermal niche for multipotent adult skin-derived precursor cells", Nat Cell Biol, 6, pp.1082~1093 (2004)
42. Chen S, "Increased expression of an epidermal stem cell marker, cytokeratin 19, in cutaneous squamous cell carcinoma", Br J Dermatol, 159, pp.952~955 (2008)
43. Lin HT, "Stem cell therapy: an exercise in patience and prudence", Philos Trans R Soc Lond B Biol Sci, 368, pp.20110334~ (2013)
44. Mavilio F, "Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells", Nat Med, 12, pp.1397~1402 (2006)
45. Ronfard V, "Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix", Transplantation, 70, pp.1588~1598 (2000)
46. Pellegrini G, "The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin", Transplantation, 68, pp.868~879 (1999)
47. De Luca M, "Regeneration of squamous epithelia from stem cells of cultured grafts", Regen Med, 1, pp.45~57 (2006)
48. Yan XL, "Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF", EGFR, Breast Cancer Res Treat, pp.2012, 132[DOI]
49. Roufosse CA, "Circulating mesenchymal stem cells", Int J Biochem Cell Biol, 36, pp.585~597 (2004)
50. Marfia G, "Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds", Organogenesis, 11, pp.183~206 (2015)
51. Sheng G, "The developmental basis of mesenchymal stem", stromal cells (MSCs), 2015, pp.15, 44~
52. Malgieri A, "Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art", Int J Clin Exp Med, 3, pp.248~269 (2010)
53. Conget PA, "Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells", J Cell Physiol, 181, pp.67~73 (1999)
54. Oswald J, "Mesenchymal stem cells can be differentiated into endothelial cells in vitro", Stem Cells, 22, pp.377~384 (2004)
55. Burdon TJ, "Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential", Bone Marrow Res, 2011, pp.207326~ (2011)
56. Ma S, "Immunobiology of mesenchymal stem cells", Cell Death Differ, 21, pp.216~225 (2014)
57. Ma OK, "Immunomodulation by mesenchymal stem cells: interplay between mesenchymal stem cells and regulatory lymphocytes", World J Stem Cells, 8, pp.268~278 (2016)
58. Castro-Manrreza ME, "Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications", J Immunol Res, 2015, pp.394917~ (2015)
59. Shin TH, "Mesenchymal stem cell therapy for inflammatory skin diseases: clinical potential and mode of action", Int J Mol Sci, 18, pp.E244~ (2017)
60. Farini A, "Clinical applications of mesenchymal stem cells in chronic diseases", Stem Cells Int, 2014, pp.306573~ (2014)
61. Ankrum JA, "Mesenchymal stem cells:immune evasive, not immune privileged", Nat Biotechnol, 32, pp.252~260 (2014)
62. Grove JE, "Plasticity of bone marrow-derived stem cells", Stem Cells, 22, pp.487~500 (2004)
63. Petrof G, "Cell therapy in dermatology", Cold Spring Harb Perspect Med, 4, pp.a015156~ (2014)
64. Körbling M, "Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells", N Engl J Med, 346, pp.738~746 (2002)
65. Chino T, "Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance", Am J Pathol, 173, pp.803~814 (2008)
66. De Luca M, "Gene therapy of inherited skin adhesion disorders: a critical overview", Br J Dermatol, 161, pp.19~24 (2009)
67. Fathke C, "Contribution of bone marrow-derived cells to skin:collagen deposition and wound repair", Stem Cells, 22, pp.812~822 (2004)
68. Sasaki M, "Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type", J Immunol, 180, pp.2581~2587 (2008)
69. Tamai K, "PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia", Proc Natl Acad Sci U S A, 108, pp.6609~6614 (2011)
70. Hu X, "Programming of the development of tumor-promoting neutrophils by mesenchymal stromal cells", Cell Physiol Biochem, 33, pp.1802~1814 (2014)
71. Vangipuram M, "Skin punch biopsy explant culture for derivation of primary human fibroblasts", J Vis Exp, (77), pp.e3779~ (2013)
72. Bilousova G, "Differentiation of mouse induced pluripotent stem cells into a multipotent keratinocyte lineage", J Invest Dermatol, 131, pp.857~864 (2011)
73. Ohta S, "Generation of human melanocytes from induced pluripotent stem cells", PLoS One, 6, pp.e16182~ (2011)
74. Hewitt KJ, "Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells", PLoS One, 6, pp.e17128~ (2011)
75. Hewitt KJ, "PDGFRβ expression and function in fibroblasts derived from pluripotent cells is linked to DNA demethylation", J Cell Sci, 125, pp.2276~2287 (2012)
76. Kim K, "Epigenetic memory in induced pluripotent stem cells", Nature, 467, pp.285~290 (2010)
77. Polo JM, "Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells", Nat Biotechnol, 28, pp.848~855 (2010)
78. Nashun B, "Reprogramming of cell fate:epigenetic memory and the erasure of memories past", EMBO J, 34, pp.1296~1308 (2015)
79. Muchkaeva IA, "Molecular mechanisms of induced pluripotency", Acta Naturae, 4, pp.12~22 (2012)
80. Miura K, "Variation in the safety of induced pluripotent stem cell lines", Nat Biotechnol, 27, pp.743~745 (2009)
81. Mayshar Y, "Identification and classification of chromosomal aberrations in human induced pluripotent stem cells", Cell Stem Cell, 7, pp.521~531 (2010)
82. Gore A, "Somatic coding mutations in human induced pluripotent stem cells", Nature, 471, pp.63~67 (2011)
83. Lin YC, "Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells", Stem Cell Res Ther, 5, pp.58~ (2014)
84. Cheng L, "Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression", Cell Stem Cell, 10, pp.337~344 (2012)
85. Szabo E, "Direct conversion of human fibroblasts to multilineage blood progenitors", Nature, 468, pp.521~526 (2010)
86. Araki R, "Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells", Nature, 494, pp.100~104 (2013)
87. de Almeida PE, "Immunogenicity of pluripotent stem cells and their derivatives", Circ Res, 112, pp.549~561 (2013)
88. Reinke JM, "Wound repair and regeneration", Eur Surg Res, 49, pp.35~43 (2012)
89. Yang RH, "Epidermal stem cells (ESCs) accelerate diabetic wound healing via the Notch signalling pathway", Biosci Rep, 36, pp.e00364~ (2016)
90. Jiménez F, "A pilot clinical study of hair grafting in chronic leg ulcers", Wound Repair Regen, 20, pp.806~814 (2012)
91. Jackson WM, "Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells", Stem Cells Transl Med, 1, pp.44~50 (2012)
92. Liu JQ, "Hair follicle units promote re-epithelialization in chronic cutaneous wounds:a clinical case series study", Exp Ther Med, 10, pp.25~30 (2015)
93. Tartarini D, "Adult stem cell therapies for wound healing: biomaterials and computational models", Front Bioeng Biotechnol, 3, pp.206~ (2016)
94. Isakson M, "Mesenchymal stem cells and cutaneous wound healing:current evidence and future potential", Stem Cells Int, 2015, pp.831095~ (2015)
95. Zahorec P, "Mesenchymal stem cells for chronic wounds therapy", Cell Tissue Bank, 16, pp.19~26 (2015)
96. Wu Y, "Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis", Stem Cells, 25, pp.2648~2659 (2007)
97. Badiavas EV, "Treatment of chronic wounds with bone marrow-derived cells", Arch Dermatol, 139, pp.510~516 (2003)
98. Falanga V, "Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds", Tissue Eng, 13, pp.1299~1312 (2007)
99. Dash NR, "Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells", Rejuvenation Res, 12, pp.359~366 (2009)
100. Hassan WU, "Role of adipose-derived stem cells in wound healing", Wound Repair Regen, 22, pp.313~325 (2014)
101. Schmidt BA, "Intradermal adipocytes mediate fibroblast recruitment during skin wound healing", Development, 140, pp.1517~1527 (2013)
102. Kim EK, "The effect of human adipose-derived stem cells on healing of ischemic wounds in a diabetic nude mouse model", Plast Reconstr Surg, 128, pp.387~394 (2011)
103. Schmidt B, "Unravelling hair follicle-adipocyte communication", Exp Dermatol, 21, pp.827~830 (2012)
104. Pang C, "An overview of the therapeutic potential of regenerative medicine in cutaneous wound healing", Int Wound J, 14, pp.450~459 (2017)
105. Pan JF, "Preparation and characterization of electrospun PLCL", Poloxamer nanofibers and dextran, PLoS One, pp.2014, 9[DOI]
106. Rodrigues C, "New therapy of skin repair combining adipose-derived mesenchymal stem cells with sodium carboxymethylcellulose scaffold in a pre-clinical rat model", PLoS One, 9, pp.e96241~ (2014)
107. Yoshikawa T, "Wound therapy by marrow mesenchymal cell transplantation", Plast Reconstr Surg, 121, pp.860~877 (2008)
108. Ravari H, "Treatment of non-healing wounds with autologous bone marrow cells, platelets, fibrin glue and collagen matrix", Cytotherapy, 13, pp.705~711 (2011)
109. Ma K, "Effects of nanofiber", stem cell composite on wound healing in acute full-thickness skin wounds, 2011, pp.17, 1413~1424
110. Naseri N, "Porous electrospun nanocomposite mats based on chitosancellulose nanocrystals for wound dressing: effect of surface characteristics of nanocrystals", Cellulose, 22, pp.521~534 (2015)
111. Yañez R, "Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease", Stem Cells, 24, pp.2582~2591 (2006)
112. Sun L, "Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans", Stem Cells, 27, pp.1421~1432 (2009)
113. Kim HS, "Human umbilical cord blood mesenchymal stem cellderived PGE2 and TGF-β1 alleviate atopic dermatitis by reducing mast cell degranulation", Stem Cells, 33, pp.1254~1266 (2015)
114. Ringdén O, "Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease", Stem Cells, 31, pp.592~601 (2013)
115. Sah SK, "Effects of human mesenchymal stem cells transduced with superoxide dismutase on imiquimod-induced psoriasis-like skin inflammation in mice", Antioxid Redox Signal, 24, pp.233~248 (2016)
116. Kim HS, "Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: phase I", IIa studies, 2017, pp.35, 248~255
117. Chen H, "Treatment of psoriasis with mesenchymal stem cells", Am J Med, 129, pp.e13~e14 (2016)
118. De Jesus MM, "Autologous adipose-derived mesenchymal stromal cells for the treatment of psoriasis vulgaris and psoriatic arthritis: a case report", Cell Transplant, 25, pp.2063~2069 (2016)
119. Wang D, "Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience", Cell Transplant, 22, pp.2267~2277 (2013)
120. Ogliari KS, "Stem cells in dermatology", An Bras Dermatol, 89, pp.286~291 (2014)
121. Cras A, "Update on mesenchymal stem cell-based therapy in lupus and scleroderma", Arthritis Res Ther, 17, pp.301~ (2015)
122. Burt RK, "Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial", Lancet, 378, pp.498~506 (2011)
123. Kühl T, "High local concentrations of intradermal MSCs restore skin integrity and facilitate wound healing in dystrophic epidermolysis bullosa", Mol Ther, 23, pp.1368~1379 (2015)
124. Fritsch A, "A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy", J Clin Invest, 118, pp.1669~1679 (2008)
125. Kern JS, "Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity", Mol Ther, 17, pp.1605~1615 (2009)
126. Conget P, "Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa", Cytotherapy, 12, pp.429~431 (2010)
127. Petrof G, "Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds:results of a randomized, vehicle-controlled trial", Br J Dermatol, 169, pp.1025~1033 (2013)
128. Venugopal SS, "A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa", J Am Acad Dermatol, 69, pp.898.e7~908.e7 (2013)
129. Schwieger-Briel A, "A COL7A1 variant leading to in-frame skipping of exon 15 attenuates disease severity in recessive dystrophic epidermolysis bullosa", Br J Dermatol, 173, pp.1308~1311 (2015)
130. Peking P, "A gene gun-mediated nonviral RNA trans-splicing strategy for Col7a1 repair", Mol Ther Nucleic Acids, 5, pp.e287~ (2016)
131. Petrof G, "Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa", J Invest Dermatol, 135, pp.2319~2321 (2015)
132. El-Darouti M, "Treatment of dystrophic epidermolysis bullosa with bone marrow non-hematopoeitic stem cells: a randomized controlled trial", Dermatol Ther, 29, pp.96~100 (2016)
133. Wagner JE, "Bone marrow transplantation for recessive dystrophic epidermolysis bullosa", N Engl J Med, 363, pp.629~639 (2010)
134. Iinuma S, "Transplanted bone marrow-derived circulating PDGFR α+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft", J Immunol, 194, pp.1996~2003 (2015)
135. Tolar J, "Hematopoietic and mesenchymal cell transplantation after myeloablative and non-myeloablative conditioning for recessive dystrophic and junctional epidermolysis bullosa (RDEB, JEB). Society of Investigative Dermatology, Venice, Italy", J Invest Dermatol, 132, pp.A534~ (2012)
136. Fujita Y, "Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice", Proc Natl Acad Sci U S A, 107, pp.14345~14350 (2010)
137. Gussoni E, "Dystrophin expression in the mdx mouse restored by stem cell transplantation", Nature, 401, pp.390~394 (1999)
138. Gussoni E, "Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation", J Clin Invest, 110, pp.807~814 (2002)
139. Ferrari G, "Failure to correct murine muscular dystrophy", Nature, 411, pp.1014~1015 (2001)
140. De Rosa L, "Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa", Stem Cell Reports, 2, pp.1~8 (2013)
141. Siprashvili Z, "Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa", JAMA, 316, pp.1808~1817 (2016)
142. Aasen T, "Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes", Nat Biotechnol, 26, pp.1276~1284 (2008)
143. Itoh M, "Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells", Proc Natl Acad Sci U S A, 108, pp.8797~8802 (2011)
144. Tolar J, "Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa", J Invest Dermatol, 131, pp.848~856 (2011)
145. Tolar J, "Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa", J Invest Dermatol, 133, pp.562~565 (2013)
146. Agarwal S, "Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients", Nature, 464, pp.292~296 (2010)
147. Bilousova G, "Exploring the therapeutic potential of induced pluripotent stem cells for the treatment of epidermolytic hyperkeratosis and epidermolysis bullosa simplex", J Invest Dermatol, 131, pp.S70~ (2011)
148. Sebastiano V, "Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa", Sci Transl Med, 6, pp.264ra163~ (2014)
149. Itoh M, "Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs)", PLoS One, 8, pp.e77673~ (2013)
150. Spiliopoulos S, "Induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa", Ann Transl Med, 3, pp.349~ (2015)
151. Lai-Cheong JE, "Revertant mosaicism in skin: natural gene therapy", Trends Mol Med, 17, pp.140~148 (2011)
152. Pasmooij AM, "Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy", Discov Med, 14, pp.167~179 (2012)
153. Gostynski A, "Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy", Br J Dermatol, 161, pp.444~447 (2009)
154. Gostyński A, "Successful therapeutic transplantation of revertant skin in epidermolysis bullosa", J Am Acad Dermatol, 70, pp.98~101 (2014)
155. Hoerter JD, "Extrafollicular dermal melanocyte stem cells and melanoma", Stem Cells Int, 2012, pp.407079~ (2012)
156. Mull AN, "Understanding melanocyte stem cells for disease modeling and regenerative medicine applications", Int J Mol Sci, 16, pp.30458~30469 (2015)
157. Tsuchiyama K, "Functional melanocytes are readily reprogrammable from multilineage-differentiating stress-enduring (muse) cells, distinct stem cells in human fibroblasts", J Invest Dermatol, 133, pp.2425~2435 (2013)
158. Lapidot T, "A cell initiating human acute myeloid leukaemia after transplantation into SCID mice", Nature, 367, pp.645~648 (1994)
159. Yumoto K, "Molecular pathways: niches in metastatic dormancy", Clin Cancer Res, 20, pp.3384~3389 (2014)
160. Clevers H, "The cancer stem cell: premises, promises and challenges", Nat Med, 17, pp.313~319 (2011)
161. Dean M, "Tumour stem cells and drug resistance", Nat Rev Cancer, 5, pp.275~284 (2005)
162. Singh A, "Keratinocyte stem cells and the targets for nonmelanoma skin cancer", Photochem Photobiol, 88, pp.1099~1110 (2012)
163. Jian Z, "Cancer stem cells in squamous cell carcinoma", J Invest Dermatol, 137, pp.31~37 (2017)
164. Lenz HJ, "Safely targeting cancer stem cells via selective catenin coactivator antagonism", Cancer Sci, 105, pp.1087~1092 (2014)
165. Krishnamurthy J, "Stem cells and the rate of living", Cell Stem Cell, 1, pp.9~11 (2007)
166. Jung Y, "Cellular mechanisms of somatic stem cell aging", Curr Top Dev Biol, 107, pp.405~438 (2014)
167. Dahl MV, "Stem cells and the skin", J Cosmet Dermatol, 11, pp.297~306 (2012)
168. Shuai Y, "Melatonin treatment improves mesenchymal stem cells therapy by preserving stemness during long-term in vitro expansion", Theranostics, 6, pp.1899~1917 (2016)
169. Drela K, "Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner", Cytotherapy, 16, pp.881~892 (2014)
170. D'Ippolito G, "Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells", Bone, 39, pp.513~522 (2006)
171. Wong TY, "Molecular mechanism of extrinsic factors affecting anti-aging of stem cells", World J Stem Cells, 7, pp.512~520 (2015)
172. Kurtz A, "Age related changes of the extracellular matrix and stem cell maintenance", Prev Med, (54Suppl), pp.S50~S56 (2012)
173. Ju Z, "Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment", Nat Med, 13, pp.742~747 (2007)

관련 논문AI추천